BackDefinium Therapeutics Overview

Definium Therapeutics Other Current Assets

Definium Therapeutics's other current assets is $8.2M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$8.22M
33.84% YoYΔ $2.08M vs prior year quarter

Peer average

Loading

Definium Therapeutics Other Current Assets History

Loading

Definium Therapeutics vs. peers: Other Current Assets Comparison

Loading

Definium Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Definium Therapeutics (DFTX) FAQ

As of the most recent data (June 2026), DFTX shows a other current assets of $8.2M. That compares with $6.1M in the prior-year period — up 33.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DFTX's other current assets is now $8.2M (was $6.1M) — a 33.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Definium Therapeutics is outperforming or lagging.

Tracking DFTX's other current assets over time shows whether Definium Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $8.2M That compares with $6.1M in the prior-year period — up 33.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Definium Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $8.2M) with ownership activity and broader fundamentals.

Definium Therapeutics's other current assets is $8.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.